Blockchain Pharmaceuticals Creates First Decentralized Pharmaceutical Company
NEW YORK, NY / ACCESSWIRE / April 21, 2021 / Blockchain Pharmaceuticals today completed development on its first layer of blocks in developing a Platform as a Service or PaaS, online scientific community, and Fractionalized Intellectual Property NFT Marketplace for Pharmaceutical Intellectual Property for scientists, developers, and engineers in the pharmaceutical, life science, and nutrition science industry. The organization now plans to register a global community of scientists and to connect them with investors and pharmaceutical developers via a coming suite of applications and API’s.
“Today, we begin Phase 1 of our initiative to disrupt and solve the problems of the global pharmaceutical industry using blockchain by lowering the costs for, increasing the value for people who need niche life-saving medicine, and implementing a new range of medicine that the typical pharmaceutical company will not look at because the investment does not bring the enormous revenue they require to sustain operations ,” says Shawn Ames, Product Owner and former Data Scientist at Pfizer, the worlds largest pharmaceutical company.
“With the advent of blockchain, and the ‘source of truth’ ledger, this can now be a problem of the past. Over the next few months, we will be building our platform with the goal of improving the drug discovery, supply-chain, and development processes to lower costs while creating Escalibrin, an immune health pill for post-COVID recovery, which will be the worlds first pharmaceutical product built entirely on blockchain,” says Ames. ‘Immune health, the most critical item in preventing COVID, has rarely been discussed in the media”.
For its Platform-as-a-Service Division, the company is also developing technology for clinical trials to assure privacy and accuracy of clinical trial data, drug tracking and tracing systems for supply-chain wide integration, R&D streamlining, and personalized medicine.
About Blockchain Pharmaceuticals
A DeFi organization, Blockchain Pharmaceuticals is a pharmaceutical company, community, and Fractionalized Intellectual Property NFT marketplace for pharmaceutical, life science, and nutrition scientists and engineers. We provide the technology, marketing, legal, compliance, and FDA regulatory backbone to pair engineering projects with scientists and drug developers, enabling them to innovate together in an entirely new way.
CONTACT
(332)-220-5487
developers@blockchainbiopharma.com
SOURCE: Blockchain Pharmaceuticals
View source version on accesswire.com:
https://www.accesswire.com/641415/BlockchainPharmaceuticalsCreates-First-Decentralized-Pharmaceutical-Company
